Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR‐α/‐γ activator properties
- 16 February 2007
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 10 (1), 10-17
- https://doi.org/10.1111/j.1463-1326.2007.00708.x
Abstract
PPARs are transcription factors belonging to the superfamily of nuclear receptors. PPAR-alpha is involved in the regulation of fatty acid (FA) uptake and oxidation, inflammation and vascular function, while PPAR-gamma participates in FA uptake and storage, glucose homeostasis and inflammation. The PPARs are thus major regulators of lipid and glucose metabolism. Synthetic PPAR-alpha or PPAR-gamma agonists have been widely used in the treatment of dyslipidaemia, hyperglycaemia and their complications. However, they are associated with an incidence of adverse events. Given the favourable metabolic effects of both PPAR-alpha and PPAR-gamma activators, as well as their potential to modulate vascular disease, combined PPAR-alpha/-gamma activation has recently emerged as a promising concept, leading to the development of mixed PPAR-alpha/-gamma activators. However, some major side effects associated with the synthetic dual activators have been reported. It is unclear whether this is a specific effect of the particular synthetic compounds or a class effect. To date, a medication that may combine the beneficial metabolic effects of PPAR-alpha and PPAR-gamma activation with fewer undesirable side effects has not been successfully developed. Pomegranate plant parts are used traditionally for the treatment of various disorders. However, only pomegranate flower has been prescribed in Unani and Ayurvedic medicines for the treatment of diabetes. This review provides a new understanding of the dual PPAR-alpha/-gamma activator properties of pomegranate flower in the potential treatment of diabetes and its associated complications.Keywords
This publication has 65 references indexed in Scilit:
- Constituents of the flowers of Punica granatumFitoterapia, 2006
- Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipidsBritish Journal of Pharmacology, 2005
- Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive ratsCanadian Journal of Physiology and Pharmacology, 2004
- Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese zucker ratsLife Sciences, 2004
- Peroxisome Proliferator-Activated Receptors and AtherogenesisCirculation Research, 2004
- Peroxisome Proliferator-Activated Receptor-α and Receptor-γ Activators Prevent Cardiac Fibrosis in Mineralocorticoid-Dependent HypertensionHypertension, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- AP-1 in cell proliferation and survivalOncogene, 2001
- Triglyceride as a risk factor for coronary artery diseaseThe American Journal of Cardiology, 1998
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994